Page last updated: 2024-11-04

sulpiride and Cannabis Abuse

sulpiride has been researched along with Cannabis Abuse in 2 studies

Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.

Research Excerpts

ExcerptRelevanceReference
"Schizophrenia is a mental illness causing disordered beliefs, ideas and sensations."2.50Cannabis and schizophrenia. ( Gillies, D; Kalakouti, E; Kyprianou, K; McLoughlin, BC; Pushpa-Rajah, JA; Rathbone, J; Variend, H, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gray, KM1
Sonne, SC1
McClure, EA1
Ghitza, UE1
Matthews, AG1
McRae-Clark, AL1
Carroll, KM1
Potter, JS1
Wiest, K1
Mooney, LJ1
Hasson, A1
Walsh, SL1
Lofwall, MR1
Babalonis, S1
Lindblad, RW1
Sparenborg, S1
Wahle, A1
King, JS1
Baker, NL1
Tomko, RL1
Haynes, LF1
Vandrey, RG1
Levin, FR1
McLoughlin, BC1
Pushpa-Rajah, JA1
Gillies, D1
Rathbone, J1
Variend, H1
Kalakouti, E1
Kyprianou, K1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Pilot Study of N-acetylcysteine for Alcohol Use Disorder[NCT04964843]Phase 20 participants (Actual)Interventional2023-04-30Withdrawn (stopped due to Null results were posted from a neurometabolite study and a recent trial for AUD. Study may resume if more positive data emerge.)
Achieving Cannabis Cessation: Evaluating N-Acetylcysteine Treatment (ACCENT)[NCT01675661]Phase 3302 participants (Actual)Interventional2014-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

The Odds of Negative Urine Cannabinoid Tests During Treatment.

The primary outcome is the abstinence rate over the 12 weeks of treatment. Abstinence is based on a weekly urine drug screen confirmed by central laboratory testing and defined as a negative cannabinoid result. (NCT01675661)
Timeframe: study weeks 2-13

,
Interventioncannabis negative urine tests (Number)
Study Week 2Study Week 3Study Week 4Study Week 5Study Week 6Study Week 7Study Week 8Study Week 9Study Week 10Study Week 11Study Week 12Study Week 13Overall
NAC Plus CM253033323236403939383433410
Placebo Plus CM212236333037373637364036401

Reviews

1 review available for sulpiride and Cannabis Abuse

ArticleYear
Cannabis and schizophrenia.
    The Cochrane database of systematic reviews, 2014, Oct-14, Issue:10

    Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Cannabinoids; Humans; Marijuana Abuse; Medical M

2014

Trials

1 trial available for sulpiride and Cannabis Abuse

ArticleYear
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
    Drug and alcohol dependence, 2017, 08-01, Volume: 177

    Topics: Acetylcysteine; Adolescent; Adult; Cannabis; Double-Blind Method; Female; Free Radical Scavengers; H

2017
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
    Drug and alcohol dependence, 2017, 08-01, Volume: 177

    Topics: Acetylcysteine; Adolescent; Adult; Cannabis; Double-Blind Method; Female; Free Radical Scavengers; H

2017
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
    Drug and alcohol dependence, 2017, 08-01, Volume: 177

    Topics: Acetylcysteine; Adolescent; Adult; Cannabis; Double-Blind Method; Female; Free Radical Scavengers; H

2017
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
    Drug and alcohol dependence, 2017, 08-01, Volume: 177

    Topics: Acetylcysteine; Adolescent; Adult; Cannabis; Double-Blind Method; Female; Free Radical Scavengers; H

2017